Header Logo

Jennifer Daly

Concepts (209)

Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.


Name Number of Publications Most Recent Publication Publications by All Authors Concept Score Why?
Liver Transplantation
6
2021
190
0.830
Why?
Mycoses
4
2012
41
0.610
Why?
Immunocompromised Host
3
2021
94
0.480
Why?
Ascomycota
1
2012
11
0.420
Why?
Bursitis
1
2012
11
0.420
Why?
Knee Injuries
1
2012
49
0.400
Why?
Kidney Transplantation
2
2017
267
0.380
Why?
Tuberculosis
2
2012
263
0.340
Why?
Antitubercular Agents
2
2012
77
0.330
Why?
Anti-Bacterial Agents
5
2000
724
0.280
Why?
Patient Compliance
1
2009
371
0.270
Why?
Imipenem
2
1997
5
0.260
Why?
Microbial Sensitivity Tests
5
2020
183
0.250
Why?
Opportunistic Infections
2
2017
27
0.230
Why?
Pleural Effusion
2
2020
33
0.210
Why?
Ganciclovir
1
2002
19
0.210
Why?
Lithiasis
1
2002
1
0.200
Why?
Actinomycosis
1
2002
2
0.200
Why?
Hemoptysis
1
2002
6
0.200
Why?
Bronchial Diseases
1
2002
8
0.200
Why?
Histoplasmosis
1
2002
23
0.200
Why?
Cytomegalovirus Infections
1
2002
69
0.200
Why?
Bronchi
1
2002
77
0.190
Why?
Antifungal Agents
3
2020
117
0.190
Why?
Lung Diseases
2
2018
164
0.180
Why?
Ampicillin
2
1997
11
0.180
Why?
DNA Polymerase III
1
2000
28
0.180
Why?
Uracil
1
2000
30
0.180
Why?
Gram-Positive Bacteria
1
2000
36
0.180
Why?
Strongyloides stercoralis
1
2020
12
0.170
Why?
Strongyloidiasis
1
2020
10
0.170
Why?
Lymphoma, Mantle-Cell
1
2020
12
0.170
Why?
Stem Cell Transplantation
1
2020
75
0.170
Why?
Antiviral Agents
1
2002
314
0.170
Why?
Enzyme Inhibitors
1
2000
341
0.150
Why?
Drug Therapy, Combination
4
2000
432
0.150
Why?
Mycobacterium haemophilum
1
2017
5
0.150
Why?
Mycobacterium Infections
1
2017
16
0.140
Why?
Critical Care
2
2020
412
0.140
Why?
Thienamycins
1
1997
1
0.140
Why?
Lung
1
2002
833
0.140
Why?
Tobramycin
1
1997
6
0.140
Why?
Penicillins
1
1997
28
0.140
Why?
Gentamicins
1
1997
22
0.140
Why?
Phylogeny
2
2021
332
0.140
Why?
Pseudomonas aeruginosa
1
1997
98
0.130
Why?
Crohn Disease
1
2017
113
0.130
Why?
Endocarditis, Bacterial
2
1993
30
0.130
Why?
Humans
24
2021
59471
0.130
Why?
Middle Aged
10
2021
16259
0.120
Why?
Staphylococcus
2
1999
16
0.120
Why?
DNA, Bacterial
2
2012
260
0.120
Why?
Rickettsiaceae
1
1993
1
0.110
Why?
Rickettsiaceae Infections
1
1993
5
0.110
Why?
Cryptococcosis
2
2008
71
0.100
Why?
Molecular Sequence Data
2
2012
1975
0.100
Why?
Tuberculosis, Pulmonary
2
2004
107
0.100
Why?
Male
12
2021
27561
0.100
Why?
Tissue Donors
1
2012
132
0.100
Why?
Bronchoscopy
2
2020
64
0.090
Why?
HLA-B Antigens
1
2010
15
0.090
Why?
Genes, MHC Class I
1
2010
28
0.090
Why?
Skin Diseases, Infectious
1
1990
10
0.090
Why?
HIV-1
2
2010
705
0.090
Why?
Immunosuppressive Agents
3
2021
303
0.090
Why?
Peritonitis
1
1990
33
0.090
Why?
Ultrasonography
1
2012
453
0.090
Why?
Massachusetts
2
2009
2095
0.090
Why?
Colitis
1
1990
76
0.080
Why?
Rifampin
1
2009
23
0.080
Why?
Isoniazid
1
2009
14
0.080
Why?
Enterococcus faecium
2
2020
6
0.080
Why?
HIV Infections
2
2010
920
0.080
Why?
Amphotericin B
1
2008
22
0.080
Why?
Antigen Presentation
1
2010
228
0.080
Why?
Antibiotic Prophylaxis
1
2008
50
0.080
Why?
Oxazoles
1
1988
10
0.080
Why?
Streptococcus
1
1988
17
0.080
Why?
Triazoles
1
2008
53
0.080
Why?
Organ Transplantation
1
2008
51
0.070
Why?
Diagnosis, Differential
2
2017
904
0.070
Why?
Kidney Failure, Chronic
2
2018
192
0.060
Why?
Candida
2
2020
34
0.060
Why?
Treatment Outcome
4
2009
5174
0.060
Why?
Time Factors
3
2002
3578
0.060
Why?
Postoperative Complications
3
2018
1133
0.060
Why?
Liver
1
2009
784
0.060
Why?
Student Health Services
1
2004
6
0.060
Why?
Communicable Disease Control
1
2004
38
0.060
Why?
Magnetic Resonance Imaging
1
2012
2038
0.050
Why?
Primary Prevention
1
2004
137
0.050
Why?
Adult
6
2009
15771
0.050
Why?
Aged
4
2020
13342
0.050
Why?
Injections, Intravenous
1
2002
148
0.050
Why?
Retrospective Studies
3
2020
6007
0.050
Why?
Incidence
3
2012
1238
0.050
Why?
Superinfection
1
2002
10
0.050
Why?
Costs and Cost Analysis
1
2002
99
0.050
Why?
Granuloma
1
2002
39
0.050
Why?
Female
6
2017
30895
0.050
Why?
Cytomegalovirus
1
2002
88
0.050
Why?
Monitoring, Physiologic
1
2002
150
0.050
Why?
Calcinosis
1
2002
79
0.050
Why?
Administration, Oral
1
2002
344
0.050
Why?
Lymph Nodes
1
2002
212
0.050
Why?
Mycophenolic Acid
1
2021
32
0.050
Why?
Polymerase Chain Reaction
1
2002
498
0.050
Why?
Tacrolimus
1
2021
39
0.050
Why?
Enterococcus
1
2000
9
0.040
Why?
Candidiasis, Invasive
1
2020
9
0.040
Why?
Thiabendazole
1
2020
3
0.040
Why?
Antiparasitic Agents
1
2020
6
0.040
Why?
Tomography Scanners, X-Ray Computed
1
2020
13
0.040
Why?
Daptomycin
1
2020
9
0.040
Why?
Blood Cell Count
1
2020
32
0.040
Why?
Ivermectin
1
2020
10
0.040
Why?
Survival Rate
1
2002
790
0.040
Why?
HIV Long Terminal Repeat
1
2000
12
0.040
Why?
Abdomen
1
2020
89
0.040
Why?
Disease Outbreaks
1
2020
104
0.040
Why?
Aged, 80 and over
1
2009
5098
0.040
Why?
Pneumonia, Staphylococcal
1
1999
12
0.040
Why?
Methicillin Resistance
1
1999
20
0.040
Why?
Young Adult
1
2009
4321
0.040
Why?
Staphylococcus aureus
1
2000
158
0.040
Why?
Candidiasis
2
2008
40
0.040
Why?
Anti-HIV Agents
1
2000
154
0.040
Why?
Dose-Response Relationship, Drug
2
1997
796
0.040
Why?
Pulmonary Atelectasis
1
2018
10
0.040
Why?
Pulmonary Edema
1
2018
25
0.040
Why?
Streptomycin
1
1997
12
0.040
Why?
Immunotherapy
1
2020
231
0.040
Why?
Drug Resistance, Multiple
1
1997
34
0.040
Why?
Gram-Positive Bacterial Infections
1
1997
30
0.040
Why?
Agar
1
1997
3
0.040
Why?
Coronary Artery Bypass
1
1999
274
0.040
Why?
Preoperative Care
1
2018
176
0.030
Why?
Fetal Blood
1
1997
70
0.030
Why?
Culture Media
1
1997
77
0.030
Why?
Surgical Wound Infection
1
1997
108
0.030
Why?
Drug Interactions
1
1997
113
0.030
Why?
Zinc
1
1997
89
0.030
Why?
Intensive Care Units
1
2020
449
0.030
Why?
In Vitro Techniques
1
1997
472
0.030
Why?
Prognosis
1
2020
1572
0.030
Why?
Temperature
1
1997
299
0.030
Why?
Viral Load
2
2010
229
0.030
Why?
Base Sequence
2
2000
1311
0.030
Why?
Pneumonia
1
2018
270
0.030
Why?
Tomography, X-Ray Computed
1
2002
1463
0.030
Why?
Drug Stability
1
1994
138
0.030
Why?
Chromatography, High Pressure Liquid
1
1994
197
0.030
Why?
Drug Resistance, Microbial
2
1997
44
0.030
Why?
Base Composition
1
1993
27
0.030
Why?
RNA, Ribosomal, 16S
1
1993
77
0.030
Why?
Prospective Studies
1
2020
3096
0.030
Why?
RNA, Bacterial
1
1993
70
0.030
Why?
Lactobacillus acidophilus
1
1992
1
0.030
Why?
Infant, Newborn
1
1997
1306
0.030
Why?
Living Donors
1
2012
65
0.020
Why?
Fatty Acids
1
1993
194
0.020
Why?
Enzyme-Linked Immunosorbent Assay
1
2012
448
0.020
Why?
HLA-C Antigens
1
2010
3
0.020
Why?
HIV Long-Term Survivors
1
2010
9
0.020
Why?
HLA-A Antigens
1
2010
12
0.020
Why?
HIV Antigens
1
2010
20
0.020
Why?
Haplotypes
1
2010
116
0.020
Why?
Immune Tolerance
1
1990
169
0.020
Why?
Amino Acids
1
2010
140
0.020
Why?
Alleles
1
2010
422
0.020
Why?
Phenotype
1
1993
1150
0.020
Why?
Genome-Wide Association Study
1
2010
322
0.020
Why?
Norfloxacin
1
1988
2
0.020
Why?
Aspergillosis
1
2008
33
0.020
Why?
Oxazolidinones
1
1988
15
0.020
Why?
Ciprofloxacin
1
1988
20
0.020
Why?
Polymorphism, Single Nucleotide
1
2010
453
0.020
Why?
Gram-Negative Bacteria
1
1988
54
0.020
Why?
Ribosomal Proteins
1
1988
41
0.020
Why?
Risk Factors
1
2018
5010
0.020
Why?
Safety
1
2008
141
0.020
Why?
Protein Conformation
1
2010
768
0.020
Why?
Cryptococcus neoformans
1
2008
141
0.020
Why?
Logistic Models
1
2010
1251
0.020
Why?
Double-Blind Method
1
2008
670
0.020
Why?
Models, Molecular
1
2010
1128
0.020
Why?
Disease Progression
1
2010
1046
0.020
Why?
CD8-Positive T-Lymphocytes
1
2010
646
0.020
Why?
Tuberculin Test
1
2004
10
0.010
Why?
Immunity, Innate
1
2010
762
0.010
Why?
Cohort Studies
1
2010
2443
0.010
Why?
Risk-Taking
1
2004
160
0.010
Why?
Universities
1
2004
151
0.010
Why?
Attitude to Health
1
2004
275
0.010
Why?
Animals
1
2020
19649
0.010
Why?
Prevalence
1
2004
1284
0.010
Why?
Reverse Transcriptase Inhibitors
1
2000
28
0.010
Why?
CD4 Lymphocyte Count
1
2000
92
0.010
Why?
DNA Primers
1
2000
291
0.010
Why?
Reference Values
1
2000
319
0.010
Why?
Vancomycin
1
1999
35
0.010
Why?
Mass Screening
1
2004
647
0.010
Why?
Lymphocytes
1
2000
193
0.010
Why?
RNA, Viral
1
2000
264
0.010
Why?
Virus Replication
1
2000
302
0.010
Why?
Risk Assessment
1
2004
1913
0.010
Why?
Lactams
1
1992
14
0.010
Why?
Aminoglycosides
1
1992
9
0.010
Why?
United States
1
2004
7516
0.010
Why?
Daly's Networks
Click the
Explore
buttons for more information and interactive visualizations!
Concepts (209)
Explore
_
Co-Authors (22)
Explore
_
Similar People (60)
Explore
_
Same Department Expand Description
Explore
_
Physical Neighbors
_